Youll also be invited to join our exclusive support group, giving you access to expert medical guidance and tailored content designed to keep you motivated
Another GLP-1 drug, liraglutide, ultimately failed in clinical trials for Alzheimers, despite showing some signal that it might slow cognitive decline
Who should avoid semaglutide Semaglutide should not be used by people with: Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Personal or family history of medullary thyroid carcinoma (MTC) Serious allergic reactions to semaglutide Be extra careful if you have pancreatic or kidney problems, diabetic retinopathy, or are pregnant or breastfeeding
doi: 10.2337/dc22-S007
Semaglutide is a compounded formulation of GLP-1, glucagon-like peptide, that is used to improve glycemic control in patients with Type 2 diabetes
This action causes individuals to feel full sooner and stay full longer, helping to control overeating